Fact checked byMindy Valcarcel, MS

Read more

April 04, 2023
1 min read
Save

UChicago Medicine Comprehensive Cancer Center joins National Comprehensive Cancer Network

Fact checked byMindy Valcarcel, MS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

The alliance of top U.S. academic cancer centers — started by 13 founding member institutions in 1995 — aims to improve and enable high-quality, effective and accessible care for patients with cancer.

Generic Institution Notes infographic

UChicago Medicine Comprehensive Cancer Center has various educational, training, clinical and research programs aimed at reaching underrepresented populations in oncology while better understanding and serving their catchment area population.

Robert W. Carlson, MD
Robert W. Carlson

“UChicago is a recognized leader in cancer care that will bring numerous strengths to our network,” Robert W. Carlson, MD, CEO of NCCN, said in a press release. “We were particularly impressed with their substantial work improving outcomes for underserved populations and longtime commitment to advancing diversity, equity and inclusion.

“They serve an ethnically and economically diverse population and have a history of higher-than-average rates of Black patients taking part in clinical trials,” he added. “Their work also includes a focus on cancer prevention through tobacco control and HPV control programs. We look forward to working with them as we continue to focus on our mission of helping all people with cancer live better lives.”

Experts from NCCN member institutions work together in 61 panels to review the latest research and drug approvals and update NCCN Clinical Practice Guidelines in Oncology.

Kunle Odunsi, MD, PhD, FRCOG, FACOG
Kunle Odunsi

“We are thrilled to join NCCN, which means our renowned faculty will contribute to evidence-based cancer treatment guidelines, research and education that will have an impact on patient care in the country and across the world,” Kunle Odunsi, MD, PhD, director of UChicago Medicine Comprehensive Cancer Center, dean for oncology in the biological sciences division and AbbVie Foundation distinguished service professor in the department of obstetrics and gynecology at University of Chicago, said in the press release. “We need to have better cancer prevention, screening, diagnosis and treatment for our communities, especially those that are underserved and face some of the worst cancer disparities.”